Endpoints News 生物医药· Anna Brown·· 2026-10-19AI 评分39
Nouscom 完成 1.35 亿美元 D 轮融资,推进核心癌症疫苗至 II 期临床
Nouscom raises $135M in Series D for lead cancer vaccine
AI 导读
临床阶段癌症生物技术公司 Nouscom 完成 1.35 亿美元超额认购的 D 轮融资。该公司将利用这笔资金推进其核心癌症疫苗进入 II 期临床试验。
正文
Clinical-stage cancer biotech Nouscom has raised $135 million in an oversubscribed Series D funding round to take its lead vaccine through to a Phase 2 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news